Krebs Biochemicals & Industries Ltd - KREBS BIOCHEM Share Price

Sector: Pharmaceuticals | ISIN: INE268B01013
₹ 68.10 (0.15%) icon3 Oct, 2023, 3:56:43 PM
Open
₹ 69.05
Prev. Close
₹ 68.00
Turnover(lac)
₹ 10.20
Day's High
₹ 71.40
Day's Low
₹ 67.65
52 Wk High
₹ 125.50
52 Wk Low
₹ 50.65
Book Value
₹ -48.60
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 146.83
P/E
0.00
EPS
0.00
Div. Yield
0.00

Krebs Biochemicals & Industries Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 10/3/2023 3:56:43 PM

    ₹ 68.1 0.10 0.15
  • Open
  • ₹ 69.05
  • Prev. Close
  • ₹ 68
  • Turnover(Lac.)
  • ₹ 10
  • Day's High
  • ₹ 71.4
  • Day's Low
  • ₹ 67.65
  • 52 Week's High
  • ₹ 125.5
  • 52 Week's Low
  • ₹ 50.65
  • Book Value
  • ₹ -48.6
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 146.83
  • P/E
  • 0
  • EPS
  • 0
  • Divi. Yield
  • 0

Krebs Biochemicals & Industries Ltd Corporate Actions

09 Aug , 2023

12:00 AM

AGM

Announcement date: 09 Aug , 2023

View Details

21 Jul , 2023

12:00 AM

21 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Jan , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

23 Jan , 2023

12:00 AM

02 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

02 Nov , 2022

12:00 AM

05 Sep , 2023

12:00 AM

BookCloser

View Details

12 Sep , 2023

12:00 AM

BookCloser

View Details

Krebs Biochemicals & Industries Ltd News and Update

Image not found
  • 6 hours ago |
  • 8:41 PM

According to a statement from Coal India Ltd (CIL), the total volume of coal delivered was 1.8 MT more than the 293 MT demand anticipated for this time period.

Image not found
  • IIFL News Service |
  • 6 hours ago |
  • 8:41 PM
Image not found
  • IIFL News Service |
  • 28 September, 2023 |
  • 8:34 PM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Krebs Biochemicals & Industries Ltd SHAREHOLDING SNAPSHOT
03 October , 2023 | 06:59 PM

PROMOTER - TOTAL72.74%

Indian: 72.74%

Foreign: 0%

NON-PROMOTER - TOTAL 27.26%

Institutions: 0.50%

Non-Institutions: 26.76%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Krebs Biochemicals & Industries Ltd FINANCIALS

No Data Available To Display Chart

Krebs Biochemicals & Industries Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Krebs Biochemicals & Industries Ltd

  • G V L Prasad
  • Independent Director
  • R T Ravi
  • Chairman (Non-Executive)
  • Avinash Ravi
  • Director
  • Tangirala Malati
  • Independent Director
  • Satish Khivsara
  • Independent Director
  • Raj Kamal Prasad Verma
  • Independent Director
  • Pabitra Bhattacharya
  • Managing Director
  • Jitendra Shah
  • Director
  • Rohit Taparia
  • Company Sec. & Compli. Officer

Summary

Krebs Biochemicals & Industries Ltd[KBIL](Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. KBIL since inception, has adopted global agenda for its growth by focusing on its specific area of expetise Fermentation Technology. During 2001-02, the company has successfully launched Vitamin C(I P Grade) through Fermentation Process.The company has also received ISO 9002 Certification for Unit I at Nellore from Yarsley International Certifications Services accredited by United Kingdom Accreditation Services. The company is now producing and marketing Lovastatin,Simvastatin and Vitamin-C. The company is now in the process of installing a co-generation power plant at Unit-II. As a step in the direction of backward integration and to capitalise on co-generation and Ethanol manufacturing the company has successfully bidded and acquired the Nannapaneni Venkatrao Co-operative Sugars Ltd located at Jampani in Guntur District of Andhra Pradesh from the Andhra Pradesh Government in Dec 28,... Read More


Reports by Krebs Biochemicals & Industries Ltd


Reports by Krebs Biochemicals & Industries Ltd

Company FAQ

No Record Found